Cornelius von Morze1, Chloe Najac1, Robert R Flavell1, David E Korenchan1, Pavithra Viswanath1, Lucas Carvajal1, John Kurhanewicz1, Sabrina M Ronen1, Daniel B Vigneron1, and David M Wilson1
1Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, CA, United States
Synopsis
The purpose of this study was to show basic
feasibility of non-invasively detecting small molecule thiols using
hyperpolarized [13C]cyanate. We detected rapid formation of the
expected hyperpolarized S-[13C]carbamyl thiol adduct after adding
cysteine to liquid hyperpolarized [13C]cyanate samples. This work
demonstrates a new non-enzymatic approach for detecting small molecule thiols
such as reduced glutathione, which could be very useful for research on
oxidative stress.Introduction
Cyanate, which exists in chemical equilibrium with urea in aqueous urea solutions, interacts with
certain nucleophilic functional groups, in particular rapidly attaching to (“carbamylating”) thiol groups in a
reversible manner
1 (Fig. 1A). The purpose of this study was to show the feasibility of non-invasively monitoring
small molecule thiol levels by temporary attachment of the hyperpolarized (HP)
13C label in situ via this reaction.
Small molecule thiols can be selectively detected using this method, while adducts formed with larger molecular
weight thiols such as cysteine residues in albumin are not detected due to short T
1 times. Reduced glutathione
(GSH) is the most prominent small molecule thiol in vivo (cellular concentration ~0.5-10mM)
2. Since GSH is a key
cellular antioxidant, non-invasive methods for GSH measurement could be very useful for biological research on
oxidative stress. We have hyperpolarized [
13C]cyanate and detected a well-resolved small molecule HP S-carbamyl thiol adduct in vitro, showing basic feasibility of this HP MR approach for small molecule thiol detection.
Methods
Potassium [
13C]cyanate (Icon Isotopes, Summit, NJ) was dissolved to ~4M in H
2O/glycerol, and
hyperpolarized via dissolution DNP to yield 40mM aqueous HP [
13C]cyanate. For proof of principle, 20mM
cysteine was added to the sample after dissolution. Non-localized HP spectra were acquired in a clinical 3T MRI
scanner. Liquid HP samples were transported to the scanner in the field of a handheld magnet, to minimize loss of
polarization due to scalar coupling with fast-relaxing
14N
3. Thermal spectra of authentic unlabeled product S-carbamyl cysteine (MP Biomedicals, Burlingame, CA) as well as the
13C-labeled raw material were also acquired
at 11.7T to confirm the identity of the observed HP product peak.
Results
The solution T
1 of [
13C]cyanate
was 58s at 3T and polarization level was 3%
(back-calculated to time of dissolution). In
addition to the primary cyanate peak and
some impurities, a small HP peak was
observed at ~8ppm downfield from the urea
reference (Fig. 1B), corresponding to the
expected thiol adduct S-[
13C]carbamyl
cysteine. This peak was absent from
samples lacking thiol and the chemical shift
of this peak matched the 11.7T thermal
spectrum of authentic product S-carbamyl
cysteine (Fig. 1C). The peak was also
clearly observed in thermal spectra of the
thiol-containing samples, obtained after the
HP experiment.
Discussion
Formation of a temporary HP
thiol adduct is a new, non-enzymatic
approach for detection of small molecule
thiols. We are working to determine whether
sufficient cellular uptake of cyanate would
occur to facilitate this reaction in vivo or in
cells on the timescale of a HP experiment.
Cyanate has relatively low toxicity in small
doses (much lower than cyanide). In a prior
study, no adverse effects were observed in
60 mice given daily i.p. injections of 32mg/kg
potassium cyanate over a five-month period.
4 Acknowledgements
We gratefully acknowledge support from NIH K01DK099451 and P41EB013598.References
1. Stark GR. J Biol Chem. 1964. 2. Meister & Anderson. Ann Rev Biochem. 1983. 3. Shang H et al.
MRM. 2015. 4. Cerami A et al. J Pharmacology & Experimental Therapeutics. 1973.